Factors responsible for neurofibrillary tangles and neuronal cell losses in tauopathy

Journal of Neuroscience Research

Volumn 89, Issue 4, 2011, Pages 576-584

  Wakasaya, Yasuhito ^a   Kawarabayashi, Takeshi ^a   Watanabe, Mitsunori ^a   Yamamoto Watanabe, Yukiko ^a   Takamura, Ayumi ^a   Kurata, Tomoko ^b   Murakami, Tetsuro ^b   Abe, Koji ^b   Yamada, Kiyofumi ^c   Wakabayashi, Koichi ^a   Sasaki, Atsushi ^d   Westaway, David ^e   Hyslop, Peter St George ^f   Matsubara, Etsuro ^a   Shoji, Mikio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apo D; DCX; Kcnab1; Npas4; Tauopathy

Indexed keywords

APOLIPOPROTEIN D; CELL PROTEIN; DOUBLECORTIN; NEURONAL PAS DOMAIN PROTEIN 4; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNAB1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; COMPARATIVE STUDY; GENE EXPRESSION; INFLAMMATION; MOUSE; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TAUOPATHY;

AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TAUOPATHIES;

EID: 79751491801     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22572     Document Type: Article

References (36)

1. Andersen JK. 2004. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10: S18-S25.
2. Belloir B, Kövari E, Surini-Demiri M, Savioz A. 2001. Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. JNeurosci Res 64: 61-69.
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
4. Boekhoorn K, Joels M, Lucassen PJ. 2006a. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis 24: 1-14.
5. Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ. 2006b. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 26: 3514-3523.
6. Boyles JK, Notterpek LM, Anderson LJ. 1990. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem 265: 17805-17815.
7. de Calignon A, Spires-Jones TL, Pitstick R, Carlson GA, Hyman BT. 2009. Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy. J Neuropathol Exp Neurol 68: 757-761.
8. Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, González C, Bastiani MJ, Rassart E, Sanchez D. 2008. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 7: 506-515.
9. Glöckner F, Ohm TG. 2003. Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuroscience 22: 103-110.
10. Hardy J. 2009. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110: 1129-1134.
11. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA. 2008. Long-term effects of Aβ42 immunization in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216-223.
12. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA. 2004. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 101: 343-347.
13. Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG. 2000. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 22: 330-336.
14. Kim SY, Volsky DJ. 2005. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6: 144.
15. Kulic L, Wollmer MA, Rhein V, Pagani L, Kuehnle K, Cattepoel S, Tracy J, Eckert A, Nitsch RM. 2010. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiol Aging [E-pub ahead of print].
16. Lin Y, Bloodgood BL, Hauser JL, Lapan AD, Koon AC, Kim TK, Hu LS, Malik AN, Greenberg ME. 2008. Activity-dependent regulation of inhibitory synapse development by Npas4. Nature 455: 1198-1204.
17. Mirochnic S, Wolf S, Staufenbiel M, Kempermann G. 2009. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 19: 1008-1018.
18. Moores CA, Perderiset M, Francis F, Chelly J, Houdusse A, Milligan RA. 2004. Mechanism of microtubule stabilization by doublecortin. Mol Cell 14: 833-839.
19. Muffat J, Walker DW. 2010. Apolipoprotein D: an overview of its role in aging and age-related diseases. Cell Cycle 9: 269-273.
20. Murakami T, Paitel E, Kawarabayashi T, Ikeda M, Chishti MA, Janus C, Matsubara E, Sasaki A, Kawarai T, Phinney AL, Harigaya Y, Horne P, Egashira N, Mishima K, Hanna A, Yang J, Iwasaki K, Takahashi M, Fujiwara M, Ishiguro K, Bergeron C, Carlson GA, Abe K, Westaway D, St. George-Hyslop P, Shoji M. 2006. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation. Am J Pathol 169: 1365-1375.
21. vβ1.1-null mutants are rescued by environmental enrichment or ageing. Eur J Neurosci 18: 1640-1644.
22. Ong WY, Hu CY, Patel SC. 2002. Apolipoprotein D in the Niemann-Pick type C disease mouse brain: an ultrastructural immunocytochemical analysis. J Neurocytol 31: 121-129.
23. Paquet D, Bhat R, Sydow A, Mandelkow EM, Berg S, Hellberg S, Fälting J, Distel M, Köster RW, Schmid B, Haass C. 2009. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest 119: 1382-1395.
24. Patel SC, Asotra K, Patel YC, McConathy WJ, Patel RC, Suresh S. 1995. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 6: 653-657.
25. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH. 2005. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309: 476-481.
26. Schindowski K, Belarbi K, Bretteville A, Ando K, Buée L. 2008. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation. Genes Brain Behav 7: 92-100.
27. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article 3.
28. Spires-Jones TL, de Calignon A, Matsui T, Zehr C, Pitstick R, Wu HY, Osetek JD, Jones PB, Bacskai BJ, Feany MB, Carlson GA, Ashe KH, Lewis J, Hyman BT. 2008. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J Neurosci 28: 862-867.
29. Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT. 2009. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci 32: 150-159.
30. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307: 1282-1288.
31. Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R, Rassart E. 1998. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem 71: 1643-1650.
32. Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. 2003. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol Psychiatry 54: 136-141.
33. Tint I, Jean D, Baas PW, Black MM. 2009. Doublecortin associates with microtubules preferentially in regions of the axon displaying actin-rich protrusive structures. J Neurosci 29: 10995-11010.
34. Verwer RW, Sluiter AA, Balesar RA, Baayen JC, Noske DP, Dirven CM, Wouda J, van Dam AM, Lucassen PJ, Swaab DF. 2007. Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin. Brain 130: 3321-3335.
35. Yun J, Koike H, Ibi D, Toth E, Mizoguchi H, Nitta A, Yoneyama M, Ogita K, Yoneda Y, Nabeshima T, Nagai T, Yamada K. 2010. Chronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brain-specific transcription factor Npas4. J Neurochem 114: 1840-1851.
36. Zhang C, McNeil E, Dressler L, Siman R. 2007. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp Neurol 204: 77-87.